There's still time to submit symposia and workshops for consideration for the 14th International Conference on #Typhoid and Other Invasive Salmonelloses.
Don't miss your chance to help shape the conversation ⬇️
https://t.co/dU9CYxsY44
La vacuna mexicana contra el Covid-19 demostró su eficacia y seguridad, como se muestra en este estudio publicado en la revista @ScienceMagazine. Además, se reducen los costos al ser producida en nuestro país.
https://t.co/eSaNr7Qut3
We are pleased to share that our latest work on the AVX/COVID-12 “Patria” vaccine has been published today in the prestigious journal Science Advances:
🔗 https://t.co/bTbJIykfHw
This marks a significant milestone in the development of vaccines in Mexico
Agradezco la entrevista de La Jornada sobre nuestra investigación. Acá la primara página de la publicación científica referida de nuestro grupo de investigación del Laboratorio de Genética y Epigenética del Desarrollo que coordino en el Instituto de Ecología de la UNAM.
Hi! We are pleased to announce that our study on the Phase 2 trial of the Patria vaccine has been published today in the journal Vaccine. 🎉🔬
📄 Download the full article here: https://t.co/pxSQqe855a
his is a significant step toward establishing the infrastructure that will provide us with scientific and technological sovereignty, driving the development of innovative vaccines to benefit our country. 💉🌎
Interactive session about @BactiVac opportunities. These were the suggestions submitted by delegates for where we should host the next LMIC Annual Network Meeting in 2026. Where would you vote for? @Slidoapp poll is still open!
#BactiVacEvents